|
Feb 21
|
Exploring Three High Growth Tech Stocks in the United States
|
|
Feb 18
|
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
|
|
Feb 17
|
Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor
|
|
Dec 30
|
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
|
|
Aug 30
|
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Aug 14
|
Q2 2024 Chimerix Inc Earnings Call
|
|
Aug 13
|
Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 13
|
Chimerix: Q2 Earnings Snapshot
|
|
Aug 13
|
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
|
|
May 2
|
Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Chimerix Inc (CMRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
|
|
May 2
|
Q1 2024 Chimerix Inc Earnings Call
|
|
May 1
|
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
|
|
Apr 24
|
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
|
|
Apr 16
|
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Apr 15
|
We Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully
|
|
Mar 21
|
Chimerix Appoints Marc D. Kozin to Board of Directors
|
|
Mar 5
|
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
|
Mar 1
|
Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
|
|
Mar 1
|
Q4 2023 Chimerix Inc Earnings Call
|